Chemclin Diagnostics Co., Ltd. (SHSE:688468) announces a share repurchase program. Under the program, the company will repurchase up to CNY 60 million worth of its A shares. The shares will be repurchased at a price not more than CNY 16.68 per share. The repurchased share will be used for employee stock ownership plan and equity incentives. The program will be funded from company's own funds. The program will be valid for a period of 12 months.

On June 6, 2024, the company amended its share repurchase program. The shares will be repurchased at a price not exceeding CNY 16.56 per share. The adjusted repurchase price cap will take effect on June 14, 2024.